학술논문
MV140 sublingual vaccine proves promising in fighting recurrent urinary tract infections in women.
Document Type
Article
Author
Source
Subject
*URINARY tract infection prevention
*SUBLINGUAL drug administration
*IMMUNIZATION
*URINARY tract infections
*ANTI-infective agents
*DISEASE relapse
*VACCINE effectiveness
*TREATMENT effectiveness
*QUALITY of life
*HEALTH behavior
*WOMEN'S health
*BEHAVIOR modification
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
1911-6470
Abstract
The article focuses on the promising efficacy of the MV140 sublingual vaccine in reducing recurrent urinary tract infections (UTIs) in women, addressing a significant health issue globally. Topics include the burden of recurrent UTIs on quality of life and healthcare systems, the efficacy of the vaccine in reducing UTI recurrences by 75 prcent in Canadian women, and its favorable safety profile, offering hope for combating recurrent UTIs and alleviating associated burdens.